BioVeteria is developing a new veterinary F(ab’)2 snake antivenom (rattlesnake antivenom, rattlesnake antivenin) produced by Veteria Labs S.A. de C.V. in Mexico City, Mexico. The polyvalent snake antivenom consists of F(ab’)2 fragments derived from horses hyperimmunized against snake venoms of Crotalus durissus and Bothrops asper. BioVeteria’s antivenom is lyophilized and has rapid reconstitution properties.
Disclaimer of Liability: In using this web site, BioVeteria Life Sciences, LLC neither warrants nor assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, opinions or procedure disclosed. It is not the intention of BioVeteria Life Sciences, LLC to provide specific regulatory advice. BioVeteria Life Sciences, LLC encourages all visitors to contact the appropriate regulatory agency for any questions or comments they may have concerning veterinary products and services.